Based on its recent analysis of the North American real-world evidence (RWE) solutions market in healthcare, Frost & Sullivan has recognized Komodo Health with the 2020 North American Company of the Year award.
Komodo Health’s comprehensive real-time Healthcare Map platform facilitates access to unified, longitudinal patient encounters. Built on this platform, the company’s software solutions allow partners to analyze data dynamically to identify unmet needs across the healthcare value chain, serving payers, providers, and pharmaceutical companies to help them achieve better outcomes.
“Komodo differentiates itself with data expertise, digital technology capability, and focus on delivering value for the customer,” said Frost & Sullivan Principal Analyst Koustav Chatterjee. “Its Healthcare Map links more than 150 comprehensive payer datasets and aggregates 65 billion clinical encounters, with 15 million newly identified patient encounters added daily and in near real-time. Leveraging AI, Komodo de-identifies and links information from over 320 million patients in the U.S. across thousands of siloed data sources while reconstructing visits from various streams. This approach makes any patient-level insight actionable.”
The Komodo Health suite of software solutions includes Aperture, Pulse, and Prism, all of which are built on the Healthcare Map. Aperture empowers life sciences teams with deep, AI-driven insights to identify and respond to disease burden patterns, and Pulse provides alerts that enable optimal provider engagement based on new patient signals. Prism is a population health analysis software that offers the flexibility to tap into the Komodo’s Healthcare Map to study and analyze patient cohorts, quickly generating powerful insights to inform market intelligence and product surveillance.
What makes Komodo Health unique is that it sources data through a vast array of relationships with commercial payer entities, which allows high-resolution and richer insights into the patient journey, including clinical encounters that are typically missed by traditional “pill-tracking” data aggregators. Komodo has partnered with Veradigm to create the largest linked EHR and claims dataset for life sciences research, and it partners with Datavant to expand its Healthcare Map to connect thousands of de-identified patient datasets.
“With COVID-19 placing significant pressure on the U.S. healthcare system, Komodo’s software solutions have proven invaluable in creating a comprehensive understanding of individual patient journeys. Today, Komodo Health works with most leading pharmaceutical companies in North America while partnering with payers, providers, and government entities,” Chatterjee said.
Read the press release here.